author-photo

Kelly A. Martin

Pfizer

9

Papers

358

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

N-benzylimidazole carboxamides as potent, orally active stearoylCoA desaturase-1 inhibitors.

2011 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (28)
Discovery of Potent, Nonsteroidal, and Highly Selective Glucocorticoid Receptor Antagonists.

2010 ChemInform
Show All
- Source
- Cite
- Save
Citations (0)
Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity.

2010 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (23)
Discovery of potent and orally bioavailable heterocycle-based β3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity

2007 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (16)
Potent and Selective, Sulfamide-Based Human β3-Adrenergic Receptor Agonists.

2004 ChemInform
Show All
- Source
- Cite
- Save
Citations (0)
Isozyme-nonselective N-Substituted Bipiperidylcarboxamide Acetyl-CoA Carboxylase Inhibitors Reduce Tissue Malonyl-CoA Concentrations, Inhibit Fatty Acid Synthesis, and Increase Fatty Acid Oxidation in Cultured Cells and in Experimental Animals

2003 Journal of Biological Chemistry
Show All
- Source
- Cite
- Save
Citations (195)
In vitro and in vivo characterization of 3-{2-[6-(2-tert-butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl}benzonitrile hydrochloride salt, a potent and selective NPY5 receptor antagonist

2003 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (24)